Takamatsu Ako, Hikosaka Makoto, Kaneko Tsuyoshi, Mikami Masashi, Kaneko Akiko
Division of Plastic Surgery, National Center for Child Health and Development, Tokyo, Japan.
Biostatistics, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
JMA J. 2021 Jan 29;4(1):50-60. doi: 10.31662/jmaj.2020-0006. Epub 2021 Jan 15.
Deformational plagiocephaly (DP) is cranial flattening on one side of the back of the skull produced by an extrinsic force on the intrinsically normal skull. When the flattening is symmetrical, the deformity is called deformational brachycephaly (DB). In the US, its prevalence has increased since the "Back to Sleep" campaign by the American Association of Pediatrics. Helmet therapy is reported to be effective in improving head deformity by multiple studies, but there are few evidences from Japan. The purpose of this study is to investigate the safety and efficacy of helmet therapy for DP, and the feasibility of introducing this treatment to the clinical setting in Japan.
This was a single-arm, retrospective, nonrandomized study. Data were collected on infants who visited the "Clinic for Baby's Head Shape" in the National Center for Child Health and Development, Tokyo, Japan, between 2011 and 2014. Improvements in Argenta classification, cranial asymmetry (CA), and cranial vault asymmetry index (CVAI) were evaluated. The relationships between CA and influencing factors were evaluated using a linear mixed-effects model.
Three hundred eighty-seven infants (273 boys and 114 girls; average age, 4.7 months) visited the clinic during the period, and 159 patients who completed the helmet therapy were analyzed. There were statistically significant improvements in Argenta classification, CA, and CVAI. Almost all of the parents reported increased sweating and mild skin irritation, but no adverse events necessitated the cessation of helmet therapy, except for one patient with increased sweating.
Helmet therapy is safe and effective in treating DP and is feasible to introduce to the clinical setting in Japan. Through the distribution of knowledge regarding the etiology and treatment of head deformity, earlier detection and an evidence-based approach to head deformity are expected in the future.
变形性斜头畸形(DP)是指在本质上正常的颅骨上,由于外部力量导致颅骨后部一侧变平。当变平是对称的时,这种畸形被称为变形性短头畸形(DB)。在美国,自美国儿科学会发起“仰卧睡眠”运动以来,其患病率有所上升。多项研究报告称头盔疗法在改善头部畸形方面有效,但日本的相关证据较少。本研究的目的是调查头盔疗法治疗DP的安全性和有效性,以及将这种治疗方法引入日本临床环境的可行性。
这是一项单臂、回顾性、非随机研究。收集了2011年至2014年期间在日本东京国立儿童健康与发展中心“婴儿头型诊所”就诊的婴儿的数据。评估了Argenta分类、颅骨不对称(CA)和颅穹不对称指数(CVAI)的改善情况。使用线性混合效应模型评估CA与影响因素之间的关系。
在此期间,有387名婴儿(273名男孩和114名女孩;平均年龄4.7个月)到该诊所就诊,对159名完成头盔疗法的患者进行了分析。Argenta分类、CA和CVAI有统计学上的显著改善。几乎所有家长都报告出汗增多和轻度皮肤刺激,但除一名出汗增多的患者外,没有不良事件导致头盔疗法停止。
头盔疗法治疗DP安全有效,并且引入日本临床环境是可行的。通过传播有关头部畸形病因和治疗的知识,预计未来对头部畸形能更早发现并采用循证方法。